
Home » Prescription Drugs 14 » RIMOSLIM Acomplia
Appetite suppressant Anti obesity drug. significantly reducing human visceral fat (the metabolically active fat wrapped around the bodys vital organs in the abdomen Liver.A single pill has been found to stop both food and cigarette cravings enough to help people quit smoking and lose weight and could also help curb other unhealthy urges. In one study the medicine helped people who were overweight drop an average of 20 pounds and in another doubled the chances that smokers would quit. Acomplia contains the active ingredient Rimonabant. It is a selective CB1 Endocannabinoid Receptor Antagonist.Rimonabant works by blocking receptors of a substance called cannabinoid 1 which stimulates hunger and other cravings in the brain and is also present in fat tissue. Active Ingredient: Rimonabant
Buy RIMOSLIM Acomplia and other Prescription Drugs 14 products online
at Medstore.
Buy Online at Medstore - Click Here!

About RIMOSLIM Acomplia:
Product Type: Prescription Drugs 14
RIMOSLIM ( Acomplia Generic Rimonabant )
RIMOSLIM (Acomplia Generic Rimonabant)
Acomplia Generic Rimonabant
20mg
Acomplia Generic Rimonabant RIMOSLIM

View more
Prescription Drugs 14
Previous Product Next Product
Prescription Drugs Online:
All the drugs you want – and not a prescription in sight. The internet makes it easy for anyone with a credit card to buy generic or regular meds from pharmacies overseas. GPs need to recognise the new reality and adapt.
A recent survey found that 15% of adults questioned had bought prescription-only medicine online without a prescription. The top medication was sold as Prozac.
Evolution is, generally speaking, a pretty sedate affair. It took a couple of billion years for fish to evolve into human beings. And, genetically speaking, we haven't changed much in the roughly 100,000 years since. But in the world that human beings have created, change moves at an ever increasing pace. In the last 20 years, the world wide web has transformed the way many of us operate almost beyond recognition. The pace of change may be dizzying but the imperative to "adapt or die" is as crucial now as it was to the primordial amoeba. We just have a lot less time to think about it.


|